<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/FAA0013E-8DC6-43D2-A16B-6B9A5E82E855"><gtr:id>FAA0013E-8DC6-43D2-A16B-6B9A5E82E855</gtr:id><gtr:name>Nigeria Institute of Medical Research</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/C745868C-1A14-451E-90DA-D92FDE99B4CA"><gtr:id>C745868C-1A14-451E-90DA-D92FDE99B4CA</gtr:id><gtr:name>University Cheikh Anta Diop de Dakar</gtr:name><gtr:address><gtr:line1>BP 5005</gtr:line1><gtr:region>Outside UK</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/847CFDD6-585B-4103-BE2A-D48D56F5A7C8"><gtr:id>847CFDD6-585B-4103-BE2A-D48D56F5A7C8</gtr:id><gtr:name>University of Ghana</gtr:name><gtr:address><gtr:line1>Box LG 74</gtr:line1><gtr:line2>Legon</gtr:line2><gtr:line4>Accra</gtr:line4><gtr:region>Outside UK</gtr:region><gtr:country>Ghana</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/DDD14154-81FB-417E-81AA-AAEA066ECA04"><gtr:id>DDD14154-81FB-417E-81AA-AAEA066ECA04</gtr:id><gtr:name>The Wellcome Trust  Sanger Institute</gtr:name><gtr:address><gtr:line1>Wellcome Trust Genome Campus</gtr:line1><gtr:line2>Hinxton</gtr:line2><gtr:postCode>CB10 1SA</gtr:postCode><gtr:region>East of England</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/055EA8B7-2C66-4FF5-96DD-63FA3AA7D0B7"><gtr:id>055EA8B7-2C66-4FF5-96DD-63FA3AA7D0B7</gtr:id><gtr:name>London Sch of Hygiene and Trop Medicine</gtr:name><gtr:address><gtr:line1>Keppel Street</gtr:line1><gtr:postCode>WC1E 7HT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/4392299B-45A0-4B1F-A45B-28B39C51452F"><gtr:id>4392299B-45A0-4B1F-A45B-28B39C51452F</gtr:id><gtr:name>Broad Institute</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/78308CAA-8483-45C0-A280-0AB4B6AD9D35"><gtr:id>78308CAA-8483-45C0-A280-0AB4B6AD9D35</gtr:id><gtr:name>Medical Research Council</gtr:name><gtr:address><gtr:line1>Polaris House</gtr:line1><gtr:line2>North Star Avenue</gtr:line2><gtr:postCode>SN2 1FL</gtr:postCode><gtr:region>South West</gtr:region></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/6083E7FB-0220-4F5F-97B0-7F6113B49A0C"><gtr:id>6083E7FB-0220-4F5F-97B0-7F6113B49A0C</gtr:id><gtr:name>MRC Unit, The Gambia</gtr:name><gtr:address><gtr:line1>MRC Laboratories, The Gambia</gtr:line1><gtr:line2>Atlantic Road PO Box 273</gtr:line2><gtr:line4>Fajara</gtr:line4><gtr:region>Outside UK</gtr:region><gtr:country>Gambia</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/6083E7FB-0220-4F5F-97B0-7F6113B49A0C"><gtr:id>6083E7FB-0220-4F5F-97B0-7F6113B49A0C</gtr:id><gtr:name>MRC Unit, The Gambia</gtr:name><gtr:address><gtr:line1>MRC Laboratories, The Gambia</gtr:line1><gtr:line2>Atlantic Road PO Box 273</gtr:line2><gtr:line4>Fajara</gtr:line4><gtr:region>Outside UK</gtr:region><gtr:country>Gambia</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/FAA0013E-8DC6-43D2-A16B-6B9A5E82E855"><gtr:id>FAA0013E-8DC6-43D2-A16B-6B9A5E82E855</gtr:id><gtr:name>Nigeria Institute of Medical Research</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/C745868C-1A14-451E-90DA-D92FDE99B4CA"><gtr:id>C745868C-1A14-451E-90DA-D92FDE99B4CA</gtr:id><gtr:name>University Cheikh Anta Diop de Dakar</gtr:name><gtr:address><gtr:line1>BP 5005</gtr:line1><gtr:region>Outside UK</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/847CFDD6-585B-4103-BE2A-D48D56F5A7C8"><gtr:id>847CFDD6-585B-4103-BE2A-D48D56F5A7C8</gtr:id><gtr:name>University of Ghana</gtr:name><gtr:address><gtr:line1>Box LG 74</gtr:line1><gtr:line2>Legon</gtr:line2><gtr:line4>Accra</gtr:line4><gtr:region>Outside UK</gtr:region><gtr:country>Ghana</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/DDD14154-81FB-417E-81AA-AAEA066ECA04"><gtr:id>DDD14154-81FB-417E-81AA-AAEA066ECA04</gtr:id><gtr:name>The Wellcome Trust  Sanger Institute</gtr:name><gtr:address><gtr:line1>Wellcome Trust Genome Campus</gtr:line1><gtr:line2>Hinxton</gtr:line2><gtr:postCode>CB10 1SA</gtr:postCode><gtr:region>East of England</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/055EA8B7-2C66-4FF5-96DD-63FA3AA7D0B7"><gtr:id>055EA8B7-2C66-4FF5-96DD-63FA3AA7D0B7</gtr:id><gtr:name>London Sch of Hygiene and Trop Medicine</gtr:name><gtr:address><gtr:line1>Keppel Street</gtr:line1><gtr:postCode>WC1E 7HT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/4392299B-45A0-4B1F-A45B-28B39C51452F"><gtr:id>4392299B-45A0-4B1F-A45B-28B39C51452F</gtr:id><gtr:name>Broad Institute</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/78308CAA-8483-45C0-A280-0AB4B6AD9D35"><gtr:id>78308CAA-8483-45C0-A280-0AB4B6AD9D35</gtr:id><gtr:name>Medical Research Council</gtr:name><gtr:address><gtr:line1>Polaris House</gtr:line1><gtr:line2>North Star Avenue</gtr:line2><gtr:postCode>SN2 1FL</gtr:postCode><gtr:region>South West</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/8EF0F6C5-99E5-493D-BA36-8ADE005F79A6"><gtr:id>8EF0F6C5-99E5-493D-BA36-8ADE005F79A6</gtr:id><gtr:firstName>Alfred</gtr:firstName><gtr:otherNames>Amambua</gtr:otherNames><gtr:surname>Ngwa</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=MC_EX_MR%2FK02440X%2F1"><gtr:id>D22FEE52-9DDF-40D6-B1DA-BE7988B85503</gtr:id><gtr:title>Plasmodium Falciparum anti-malaria drug resistance in The Gambia: Identification of potential genetic markers by retrospective whole genome approaches</gtr:title><gtr:status>Active</gtr:status><gtr:grantCategory>Fellowship</gtr:grantCategory><gtr:grantReference>MC_EX_MR/K02440X/1</gtr:grantReference><gtr:abstractText>Many cheap drugs like chloroquine and Fansidar fail to treat al malaria infections due to drug resistance. It now requires the use of expensive combinations containing the compound artemisinin (ART) to treat infections. However, there are indications that some infections with malaria in South East Asia are have again developed resistance to these new drug combinations. This can spread to Africa which bears 90% of malaria cases. This project therefore seeks to determine the genetic causes of antimalarial drug resistance n Africa. It will employ new technologies to comprehensively study genetic differences in the parasites from the period before ACTs through five years of its use in the West African state, The Gambia. At community level, the project will also look at how parasites will be cleared from infected people being treated with ACTs. Communities with parasites that remain in blood after treatment will be the focus of further genetic. This project will last for 48 months. It will build collaboration between MRC Unit, The Gambia, UK and US institutions for analysis and technology transfer. The findings from the project should inform policy makers on developing new intervention strategies that will incorporate the peculiarities of populations studied.</gtr:abstractText><gtr:technicalSummary>The project aims at characterizing genetic mechanisms of antimalarial drug resistance in a West African population by adopting an innovative retrospective genomic approach to produce data on genome-wide signatures of selection from drugs and their association with parasite response to current artemisinin-based antimalarials. The major scientific goal will be achieved by combining epidemiology, innovative parasite genomic and phenotyping technologies to identify novel genetic markers that can be developed into tools for surveillance and containment of antimalarial drug resistance, via the following specific research objectives;
1. To characterize patterns of genomic variation prior to and since the introduction of artemisinin-based combination therapies (ACTs). The selection of genetic loci enabling adaptation to drug resistance would increase their frequency over time as they are under directional selection. Genome wide microsatellite analysis and sequencing for nucleotide polymorphisms in archived samples collected between 2003 and 2013 will employ Bioinformatic and statistical methods to determine the evolution of infection complexity and selective sweeps following the implementation of ACTs. Candidate markers identified will be further studied in current natural infections.
2. To identify possible 'hotspots' of drug resistance and transmission. Hypothetically, the prevalence of drug resistant parasite genotypes will vary between communities with intensity of transmission and access to drugs. Communities in The Gambia with varying prevalence of candidate markers of resistance identified from retrospective surveys will be identified by analyzing samples collected within the ongoing program grant entitled 'Dynamics of malaria transmission and determinants of heterogeneity'. Infected samples will be genotyped for candidate drug resistance markers identified by retrospective analysis (objective 1). Two communities, one with high and the other with low prevalence of resistant genotypes will be compared for ex vivo and in vivo parasite drug sensitivity. 
3. To determine the association between predicted genetic markers, ex vivo drug sensitivities and gametocyte conversion rates. It is expected that parasites from communities with higher prevalence of candidate drug resistance markers will have reduced ex vivo sensitivity to drugs. Parasite isolates from study villages identified in objective 2, will be tested against artemisinin and partner antimalarials following recent protocols that can distinguish the effect of these drugs on early developmental blood stages. Each isolate will also be analysed for gametocyte production to determine the fitness cost to resistant genotypes. Recurrent infections within 42 days of treatment will also be analysed for phenotypic and genotypic adaptation to drugs. Characterized phenotypes (susceptible/resistant) will undergo genome sequencing and association analysis.</gtr:technicalSummary><gtr:fund><gtr:end>2018-02-28</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2013-06-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>0</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>The Wellcome Trust Sanger Institute</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Plasmodium Genomic Diversity Studies</gtr:description><gtr:id>4CFEAD79-1913-4F61-9FA7-875F0C757E2A</gtr:id><gtr:impact>Scientific publications. 
Disciplines: biology; population genetics; bioinformatics; statistics.</gtr:impact><gtr:outcomeId>5460db5690db69.22464545-2</gtr:outcomeId><gtr:partnerContribution>Capacity building in the form of training, genomics, sample sequencing, whole genomic sequencing and bioinformatic analysis.</gtr:partnerContribution><gtr:piContribution>Field exploration and sampling.</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Universit? Cheikh Anta Diop de Dakar, Dakar</gtr:collaboratingOrganisation><gtr:country>Senegal, Republic of</gtr:country><gtr:description>Plasmodium Genomic Diversity Studies</gtr:description><gtr:id>A60DC96E-08F9-4A0F-91D4-D74E0A95826D</gtr:id><gtr:impact>Scientific publications. 
Disciplines: biology; population genetics; bioinformatics; statistics.</gtr:impact><gtr:outcomeId>5460db5690db69.22464545-6</gtr:outcomeId><gtr:partnerContribution>Capacity building in the form of training, genomics, sample sequencing, whole genomic sequencing and bioinformatic analysis.</gtr:partnerContribution><gtr:piContribution>Field exploration and sampling.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Nigeria Institute of Medical Research</gtr:collaboratingOrganisation><gtr:country>Nigeria, Federal Republic of</gtr:country><gtr:description>Plasmodium Genomic Diversity Studies</gtr:description><gtr:id>41814133-621C-4998-933F-CA36C98107AE</gtr:id><gtr:impact>Scientific publications. 
Disciplines: biology; population genetics; bioinformatics; statistics.</gtr:impact><gtr:outcomeId>5460db5690db69.22464545-5</gtr:outcomeId><gtr:partnerContribution>Capacity building in the form of training, genomics, sample sequencing, whole genomic sequencing and bioinformatic analysis.</gtr:partnerContribution><gtr:piContribution>Field exploration and sampling.</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Broad Institute</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>Plasmodium Genomic Diversity Studies</gtr:description><gtr:id>0A03A71D-D9D4-4EEF-A9D4-111DABC5E252</gtr:id><gtr:impact>Scientific publications. 
Disciplines: biology; population genetics; bioinformatics; statistics.</gtr:impact><gtr:outcomeId>5460db5690db69.22464545-4</gtr:outcomeId><gtr:partnerContribution>Capacity building in the form of training, genomics, sample sequencing, whole genomic sequencing and bioinformatic analysis.</gtr:partnerContribution><gtr:piContribution>Field exploration and sampling.</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Ghana</gtr:collaboratingOrganisation><gtr:country>Ghana, Republic of</gtr:country><gtr:department>West Africa Centre for Cell Biology of Infectious Pathogens (WACCBIP)</gtr:department><gtr:description>West African Centre for Cell Biology of infectious pathogens (WACCBIP)</gtr:description><gtr:id>01EB9042-F9B6-4BE1-AD64-319584E40F89</gtr:id><gtr:impact>This is a training programme and the major outcome for now has been the funding for the training of 3 PhD and 1 Postdoctoral fellow.</gtr:impact><gtr:outcomeId>56e08defab4fc8.73984023-1</gtr:outcomeId><gtr:partnerContribution>The consortium is hosted at the University of Ghana. The funding programmes for training are hosted by WACCBIP. They are providing funding for travels and training of PhD and Postdoctoral fellow. The WACCBIP parasitology labs is also providing samples for transAfrican genomics analysis of Plasmodium falciparum.</gtr:partnerContribution><gtr:piContribution>I participated in proposal submissions to the World Bank and Wellcome Trust foundation for training funds for graduates. Both the WACCBIP and WACCBIP-DELTAS proporsals were accepted. Through these funds my group will be funded to host 3 PhD and one Postdoctoral trainees. I participated in grant writing, application evaluation and interviews of potential candidates for fellowships.
I participate in teaching and seminar presentations for graduate students in the WACCBIP training programme.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Medical Research Council (MRC)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>MRC Centre for Genomics and Global Health</gtr:department><gtr:description>Plasmodium Genomic Diversity Studies</gtr:description><gtr:id>E693BC1B-3675-4CEC-B3A9-0A7A9B36EDF8</gtr:id><gtr:impact>Scientific publications. 
Disciplines: biology; population genetics; bioinformatics; statistics.</gtr:impact><gtr:outcomeId>5460db5690db69.22464545-1</gtr:outcomeId><gtr:partnerContribution>Capacity building in the form of training, genomics, sample sequencing, whole genomic sequencing and bioinformatic analysis.</gtr:partnerContribution><gtr:piContribution>Field exploration and sampling.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>London School of Hygiene and Tropical Medicine (LSHTM)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Plasmodium Genomic Diversity Studies</gtr:description><gtr:id>A9256F5E-E3F2-4766-A62D-755FEF682A86</gtr:id><gtr:impact>Scientific publications. 
Disciplines: biology; population genetics; bioinformatics; statistics.</gtr:impact><gtr:outcomeId>5460db5690db69.22464545-3</gtr:outcomeId><gtr:partnerContribution>Capacity building in the form of training, genomics, sample sequencing, whole genomic sequencing and bioinformatic analysis.</gtr:partnerContribution><gtr:piContribution>Field exploration and sampling.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>The Wellcome Trust Sanger Institute</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>West African Malaria Invasion Network (WAMIN)</gtr:description><gtr:id>8F0D58CC-BA88-47F7-882C-54F18036ABBB</gtr:id><gtr:impact>1. Training workshop for laboratory team on parasite invasion assays held in Dakar in December 2015. This Workshop allowed for the training of 2 of my laboratory staff on Plasmodium falciparum invasion mechanism analysis. We have since phenotyped 200 hundred isolates in my lab and a manuscript is being prepared for publication.
2. A welcome Trust Collborative grant submission has been reviewed and currently at the interview stage. We participated in the writing of the grant. If successful, my lab will receive financial support for parassite recruitment and phenoptyping for the next 5 years</gtr:impact><gtr:outcomeId>58c9abf10bcac3.72476197-1</gtr:outcomeId><gtr:partnerContribution>The Wellcome trust will provide the technology and platforms for new phenotypic assays and for transcriptome analysis
The WACCBIP centre at the University of Ghana will be coordinating the collaborative grant</gtr:partnerContribution><gtr:piContribution>My team is host one of the collaborating site on the WAMIN collaborative grant to the Wellcome Trust. We will recruit and phenotype Plasmodium falciparum isolates for phenotypic functional analysis of invasion mechanisms of this malaria parasite.</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2016-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Medical Research Council Unit open day</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>44FAFF89-106C-4D4E-A47A-869A33249F0C</gtr:id><gtr:impact>More than 100 pupils from local schools in the Gambia visit the Unit. I received 5 applications for attarchment from school leavers who wish to experience laboratory research.</gtr:impact><gtr:outcomeId>56e09367916708.32783551</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2013,2014,2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Medical Research Council Unit open day</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>D8711848-0CA2-458C-B3CD-69E9F0C93135</gtr:id><gtr:impact>More than 100 pupils from local schools in the Gambia visit the Unit. I received 5 applications for attarchment from school leavers who wish to experience laboratory research.</gtr:impact><gtr:outcomeId>56e09376f068a0.40746113</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2013,2014,2015</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>400000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>DELTAS</gtr:description><gtr:end>2021-02-02</gtr:end><gtr:fundingOrg>Wellcome Trust</gtr:fundingOrg><gtr:id>15CCA335-96D7-4963-9EB3-60726EDC395F</gtr:id><gtr:outcomeId>56e090a75e9375.24775268</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2016-02-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>20000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>MRC Centre for Genomics and Global Health</gtr:department><gtr:description>PDN Award</gtr:description><gtr:end>2014-06-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:fundingRef>R31087/CN003</gtr:fundingRef><gtr:id>B48D585C-EA77-4D10-B144-3D77C85AC982</gtr:id><gtr:outcomeId>5460d55d5207b9.28350710</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-04-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs><gtr:researchDatabaseAndModelOutput><gtr:description>Short sequence read archive</gtr:description><gtr:id>D85B7235-893B-4826-B8E2-D8C5EE02E9B5</gtr:id><gtr:impact>We have contributed material of Gambian Plasmodium falciparum sequences that is accessible to the wider research community. the Gambia sequences have been used in over 20 publications till date.</gtr:impact><gtr:outcomeId>5460ddfea53be6.59191300</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>Plasmodium falciparum, ENA Database</gtr:title><gtr:type>Database/Collection of data</gtr:type></gtr:researchDatabaseAndModelOutput><gtr:researchDatabaseAndModelOutput><gtr:description>PlasmoDB is a repository for Plasmodium research data from across the world. We have contributed consensus sequences from our whole genome sequencing analysis. We have also contributed proteome antibody hybridisation data from the Gambia on selected assymptomatic and clinically infected cases</gtr:description><gtr:id>0C7B6D33-FC16-4E37-94C1-1BE93CC4848D</gtr:id><gtr:impact>The database is available to the malaria community</gtr:impact><gtr:outcomeId>56e096a33f7e94.30736953</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>Plasmodium database (PlasmoDB)</gtr:title><gtr:type>Database/Collection of data</gtr:type></gtr:researchDatabaseAndModelOutput></gtr:researchDatabaseAndModelOutputs><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>I developed new fragment analysis assays for 35 microsatellite loci targeting signatures of selection from drugs and interventions that reduce transmission. These are now being applied to study populations across the African continent. We have also developed a pipeline for genotyping of whole genome micrisatellites from Next Generation sequencing data of wild isolates. This will increase the interrogation of structural variations in the Genome of the parasite and the determination of population structure as infection prevalence decrease across Africa</gtr:description><gtr:id>C9E7DD30-F138-4C37-93F3-483241C7F8DB</gtr:id><gtr:impact>We can now define the length and diversity of haplotypes in new selective sweeps from chromosome 6 of the malaria parasite.</gtr:impact><gtr:outcomeId>56e095506f0c74.65806880</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>New microsatellite assays of Plasmodium falciparum selective sweeps</gtr:title><gtr:type>Technology assay or reagent</gtr:type><gtr:yearFirstProvided>2015</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:id>C87D6A11-947E-46E8-B950-A049D2298D88</gtr:id><gtr:outcomeId>56e0953c1017d8.72471617</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>BD0C819C-F844-43A0-B3EE-0FA1BE802767</gtr:id><gtr:title>Multiplication rate variation in the human malaria parasite Plasmodium falciparum.</gtr:title><gtr:parentPublicationTitle>Scientific reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d2f1bc7bbf2d9a6533a0c9aa5158fcd9"><gtr:id>d2f1bc7bbf2d9a6533a0c9aa5158fcd9</gtr:id><gtr:otherNames>Murray L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>2045-2322</gtr:issn><gtr:outcomeId>5aa7ca0e918145.89928959</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>25979D9C-5AB7-463F-B5E6-BFAAF280A3FA</gtr:id><gtr:title>Delayed parasite clearance after treatment with dihydroartemisinin-piperaquine in Plasmodium falciparum malaria patients in central Vietnam.</gtr:title><gtr:parentPublicationTitle>Antimicrobial agents and chemotherapy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f922eb2a91667934e2a32faf3822bcf3"><gtr:id>f922eb2a91667934e2a32faf3822bcf3</gtr:id><gtr:otherNames>Thriemer K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0066-4804</gtr:issn><gtr:outcomeId>5460d0debe91d6.69367520</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5818BA1A-1BFE-4E6E-9BC9-3619565D6937</gtr:id><gtr:title>Variation in Plasmodium falciparum erythrocyte invasion phenotypes and merozoite ligand gene expression across different populations in areas of malaria endemicity.</gtr:title><gtr:parentPublicationTitle>Infection and immunity</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cd816cc7ea5e5ffab5a6d980f41f6072"><gtr:id>cd816cc7ea5e5ffab5a6d980f41f6072</gtr:id><gtr:otherNames>Bowyer PW</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0019-9567</gtr:issn><gtr:outcomeId>56e0899f48b7d3.91219098</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A02ADAE2-3CF2-4BD6-B587-1887C5B3918F</gtr:id><gtr:title>K13-propeller polymorphisms in Plasmodium falciparum parasites from sub-Saharan Africa.</gtr:title><gtr:parentPublicationTitle>The Journal of infectious diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3e516e23cb40d58db86a1a4d61d1edd3"><gtr:id>3e516e23cb40d58db86a1a4d61d1edd3</gtr:id><gtr:otherNames>Kamau E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0022-1899</gtr:issn><gtr:outcomeId>5460d0a6ee9eb1.08407051</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>70CA4888-52D5-487D-A603-FB50A4547F21</gtr:id><gtr:title>Population Structure Shapes Copy Number Variation in Malaria Parasites.</gtr:title><gtr:parentPublicationTitle>Molecular biology and evolution</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0ee3aec6f5ed886f349186379a4802bc"><gtr:id>0ee3aec6f5ed886f349186379a4802bc</gtr:id><gtr:otherNames>Cheeseman IH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0737-4038</gtr:issn><gtr:outcomeId>56e0899ece06c3.43720648</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5C39FDE1-D0E5-43DF-872D-F685CD5184D9</gtr:id><gtr:title>Exceptionally long-range haplotypes in Plasmodium falciparum chromosome 6 maintained in an endemic African population.</gtr:title><gtr:parentPublicationTitle>Malaria journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0dc2dcf13cb60a8294fc0d56e088301a"><gtr:id>0dc2dcf13cb60a8294fc0d56e088301a</gtr:id><gtr:otherNames>Amambua-Ngwa A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1475-2875</gtr:issn><gtr:outcomeId>58c9a8f38af613.29921727</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5B2AA0A0-EF44-4A3A-BFD6-80D87591803B</gtr:id><gtr:title>Genome-wide analysis of selection on the malaria parasite Plasmodium falciparum in West African populations of differing infection endemicity.</gtr:title><gtr:parentPublicationTitle>Molecular biology and evolution</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8e29b1d8caca77358dfa48527127661a"><gtr:id>8e29b1d8caca77358dfa48527127661a</gtr:id><gtr:otherNames>Mobegi VA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0737-4038</gtr:issn><gtr:outcomeId>5460d0a7d292a2.56745634</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4BC30DFD-7730-41AF-9B4A-E8C98535B0AB</gtr:id><gtr:title>Multiple populations of artemisinin-resistant Plasmodium falciparum in Cambodia.</gtr:title><gtr:parentPublicationTitle>Nature genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/75c4cab9c5760d4acbdaeb780d2b0b6b"><gtr:id>75c4cab9c5760d4acbdaeb780d2b0b6b</gtr:id><gtr:otherNames>Miotto O</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1061-4036</gtr:issn><gtr:outcomeId>5460d0a8695ff7.18875660</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9A577320-0056-4ADE-928A-8B2EB475A331</gtr:id><gtr:title>Genomic epidemiology of artemisinin resistant malaria.</gtr:title><gtr:parentPublicationTitle>eLife</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f8158a7b97f9cda79f60ba71ee6a6a75"><gtr:id>f8158a7b97f9cda79f60ba71ee6a6a75</gtr:id><gtr:otherNames>MalariaGEN Plasmodium falciparum Community Project</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2050-084X</gtr:issn><gtr:outcomeId>58c9a8f3cb2274.51479040</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E7710FAD-7437-4583-AB01-7608D9B0E80F</gtr:id><gtr:title>Pooled-DNA sequencing identifies genomic regions of selection in Nigerian isolates of Plasmodium falciparum.</gtr:title><gtr:parentPublicationTitle>Parasites &amp; vectors</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/449064afb169ca15a8d516ec268bcdcb"><gtr:id>449064afb169ca15a8d516ec268bcdcb</gtr:id><gtr:otherNames>Oyebola KM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1756-3305</gtr:issn><gtr:outcomeId>5aa7ca0eb85a53.26945967</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C2C7B0FC-AF73-4F63-8C39-D509E5A6948A</gtr:id><gtr:title>Severe Malaria Not Responsive to Artemisinin Derivatives in Man Returning from Angola to Vietnam.</gtr:title><gtr:parentPublicationTitle>Emerging infectious diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/292cb70f4d613c92b07f9a3a23e9e377"><gtr:id>292cb70f4d613c92b07f9a3a23e9e377</gtr:id><gtr:otherNames>Van Hong N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1080-6040</gtr:issn><gtr:outcomeId>56e0899f24b913.34865515</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7AFE8AEF-7113-4FC4-87E1-279CD5C8A61F</gtr:id><gtr:title>Molecular markers for artemisinin and partner drug resistance in natural Plasmodium falciparum populations following increased insecticide treated net coverage along the slope of mount Cameroon: cross-sectional study.</gtr:title><gtr:parentPublicationTitle>Infectious diseases of poverty</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c331ffefa59854e98bd12782e3f9eb9f"><gtr:id>c331ffefa59854e98bd12782e3f9eb9f</gtr:id><gtr:otherNames>Apinjoh TO</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>2049-9957</gtr:issn><gtr:outcomeId>5aa7ca0e6d0a67.01691155</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>770A892D-1643-4CF1-8C13-DC6F13CD8B2E</gtr:id><gtr:title>SustainedSusceptibility of Plasmodium falciparum to Artemisinin Derivatives but Increasing Tolerance to Artemisinin Combination Therapy Partner Quinolines in The Gambia.</gtr:title><gtr:parentPublicationTitle>Antimicrobial agents and chemotherapy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0dc2dcf13cb60a8294fc0d56e088301a"><gtr:id>0dc2dcf13cb60a8294fc0d56e088301a</gtr:id><gtr:otherNames>Amambua-Ngwa A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0066-4804</gtr:issn><gtr:outcomeId>5aa7ca0da8cc36.42331379</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3A363BF8-0B86-4D2F-B126-13C6E18A8AEF</gtr:id><gtr:title>Microsatellite markers reveal low levels of population sub-structuring of Plasmodium falciparum in southwestern Nigeria.</gtr:title><gtr:parentPublicationTitle>Malaria journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e6d83ef12d2c5160cc8e591c4d69e42d"><gtr:id>e6d83ef12d2c5160cc8e591c4d69e42d</gtr:id><gtr:otherNames>Oyebola MK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1475-2875</gtr:issn><gtr:outcomeId>56e0899fd2f546.35386301</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>736A4C72-3904-49D8-9201-1CC73A13238E</gtr:id><gtr:title>Severe malaria not responsive to artemisinin derivatives in man returning from Angola to Vietnam.</gtr:title><gtr:parentPublicationTitle>Emerging infectious diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/292cb70f4d613c92b07f9a3a23e9e377"><gtr:id>292cb70f4d613c92b07f9a3a23e9e377</gtr:id><gtr:otherNames>Van Hong N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1080-6040</gtr:issn><gtr:outcomeId>5460d0a74c53d9.19067483</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">MC_EX_MR/K02440X/1</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>03BA7BC9-C251-48FC-8EA9-5F7414A63FEE</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Infection</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>CDB856E6-DF2D-4D96-88BD-1CC96FE277EF</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>2.2  Factors relating to physical environment</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>